Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
44.65
-1.88 (-4.04%)
Sep 11, 2026, 3:00 PM CST
| Market Cap | 8.08B -14.1% |
| Revenue (ttm) | 1.34B +0.1% |
| Net Income | 277.24M +21.4% |
| EPS | 1.60 +23.1% |
| Shares Out | 173.57M |
| PE Ratio | 29.08 |
| Forward PE | 28.55 |
| Dividend | 0.49 (1.09%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 2,395,351 |
| Open | 46.22 |
| Previous Close | 46.53 |
| Day's Range | 43.88 - 46.90 |
| 52-Week Range | 40.25 - 80.48 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |